CRLBF · Cresco Labs Inc.
Market Cap
$286.71M
Shares
372.35M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.78
Open$0.77
Day$0.74–0.79
52W close$0.64–1.92
Avg vol 30d401K
Short int1.4M · 0.4% float · 2.3d
Short vol51%
Last earningsAug 6, 2026
DataJan 2020–Sep 2026
Up next
Next earnings call
Oct 22, 2026
Est · unconfirmed
· in 7 wks
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
-50.8%
Trailing year
Short interest
0.4%
Latest settlement · 2.3 days to cover
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bearish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 15.2 · calm
Equity put/call 0.56
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−17%
below
Price vs 50-day avg
+4%
above
RSI (14)
53
neutral
MACD trend
Negative
52-week position
11%
near low
Momentum
relative strength
1-month return
+22%
trailing
6-month return
−18%
trailing
YTD return
−36%
this year
Relative strength
−33%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-33% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.38% of float · ▲ +26.1% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 4-yr range
Squeeze score
47
elevated · 0–100
Fundamentals
Revenue growth
−9%
Y/Y
Gross margin
49%
contracting
EPS growth
−73%
Y/Y
Free cash flow
$37.8M
Quant / Vol
risk profile
Volatility
140%
annualized · 1-yr
Max drawdown
−67%
past year
ATR
8.1%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−17%
Bearish
Price vs 50-day avg
+4%
Bullish
RSI (14)
53
Neutral
MACD trend
Negative
Bearish
52-week position
11%
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Distributing
-33% holders QoQ · +1 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.38% of float · ▲ +26.1% MoM · 2.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
6 holders — mid 4-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 11%
Range high $2
vs 200-day avg -17%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRLBF
this stock
Cresco Labs Inc.
|
$286.71M | -36.3% | -9.5% | — | 0.4% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$66.37B | — | — | — | 0.0% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$58.66B | +18.2% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$47.69B | -1.7% | — | — | 0.0% |
|
HLN
Haleon plc
|
$44.35B | -2.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
6
- % held
- 0.0%
- Net QoQ
- -135.7K sh
- Top holder
- ALBERT D MASON INC
Held
Float
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRLBF | +6.0% | +22.1% | -17.7% | +0.5% | -36.3% |
| SPY | -0.1% | -0.6% | +14.9% | -0.3% | +12.2% |
| vs SPY | +6.1% | +22.7% | -32.5% | +0.8% | -48.5% |